Original languageEnglish (US)
Pages (from-to)1143-1144
Number of pages2
JournalThe Lancet Oncology
Volume19
Issue number9
DOIs
StatePublished - Sep 2018

Fingerprint

B-Cell Chronic Lymphocytic Leukemia
4-(4-((2-(4-chlorophenyl)-4,4-dimethylcyclohex-1-en-1-yl)methyl)piperazin-1-yl)-N-((3-nitro-4-((tetrahydro-2H-pyran-4-ylmethyl)amino)phenyl)sulfonyl)-2-(1H-pyrrolo(2,3-b)pyridin-5-yloxy)benzamide

ASJC Scopus subject areas

  • Oncology

Cite this

Venetoclax in chronic lymphocytic leukaemia : a possible cure? / Kallam, Avyakta; Armitage, James Olen.

In: The Lancet Oncology, Vol. 19, No. 9, 09.2018, p. 1143-1144.

Research output: Contribution to journalComment/debate

@article{587a5dd207364167935356aaebe54ece,
title = "Venetoclax in chronic lymphocytic leukaemia: a possible cure?",
author = "Avyakta Kallam and Armitage, {James Olen}",
year = "2018",
month = "9",
doi = "10.1016/S1470-2045(18)30442-X",
language = "English (US)",
volume = "19",
pages = "1143--1144",
journal = "The Lancet Oncology",
issn = "1470-2045",
publisher = "Lancet Publishing Group",
number = "9",

}

TY - JOUR

T1 - Venetoclax in chronic lymphocytic leukaemia

T2 - a possible cure?

AU - Kallam, Avyakta

AU - Armitage, James Olen

PY - 2018/9

Y1 - 2018/9

UR - http://www.scopus.com/inward/record.url?scp=85056232591&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85056232591&partnerID=8YFLogxK

U2 - 10.1016/S1470-2045(18)30442-X

DO - 10.1016/S1470-2045(18)30442-X

M3 - Comment/debate

C2 - 30115595

AN - SCOPUS:85056232591

VL - 19

SP - 1143

EP - 1144

JO - The Lancet Oncology

JF - The Lancet Oncology

SN - 1470-2045

IS - 9

ER -